uniQure N.V.(QURE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

QURE uniQure N.V.

盘后交易 11-15 16:16:56 EST

6.21

-0.54

-8.07%

盘后6.16

-0.04-0.73%

16:07 EST

最高6.83	最低5.99	成交量83.27万
今开6.78	昨收6.75	日振幅12.44%
总市值3.02亿	流通市值2.51亿	总股本4,874万
成交额528.53万	换手率2.05%	流通股本4,053万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"QURE","market":"US","secType":"STK","nameCN":"uniQure N.V.","latestPrice":6.205,"timestamp":1731704400000,"preClose":6.75,"halted":0,"volume":832714,"hourTrading":{"tag":"盘后","latestPrice":6.16,"preClose":6.205,"latestTime":"16:07 EST","volume":1,"amount":6.16,"timestamp":1731704879420},"delay":0,"floatShares":40530871,"shares":48743140,"eps":-4.94956,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.545,"latestTime":"11-15 16:16:56 EST","open":6.78,"high":6.83,"low":5.99,"amount":5285250.163952,"amplitude":0.124444,"askPrice":6.75,"askSize":800,"bidPrice":6.16,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-4.94956,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1731718800000},"adr":0,"listingDate":1391576400000,"adjPreClose":6.75,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":6.16,"preClose":6.205,"latestTime":"16:07 EST","volume":1,"amount":6.16,"timestamp":1731704879420},"volumeRatio":1.098867,"impliedVol":1.1535,"impliedVolPercentile":0.9008},"requestUrl":"/m/hq/s/QURE","defaultTab":"news","newsList":[{"id":"2483583055","title":"Uniqure N.V.盘中异动 股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483583055","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483583055?lang=zh_cn&edition=full","pubTime":"2024-11-16 02:12","pubTimestamp":1731694362,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日02时12分，Uniqure N.V.股票出现波动，股价大幅跳水5.19%。截至发稿，该股报6.40美元/股，成交量27.7283万股，换手率0.57%，振幅5.48%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为3.48%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116021242abc55456&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116021242abc55456&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2483585533","title":"Uniqure N.V.盘中异动 股价大涨5.05%报7.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483585533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483585533?lang=zh_cn&edition=full","pubTime":"2024-11-14 02:45","pubTimestamp":1731523543,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日02时45分，Uniqure N.V.股票出现异动，股价快速上涨5.05%。截至发稿，该股报7.07美元/股，成交量32.2744万股，换手率0.66%，振幅5.50%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.32%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114024543abbe5d3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114024543abbe5d3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2482430753","title":"Uniqure N.V.盘中异动 股价大涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482430753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482430753?lang=zh_cn&edition=full","pubTime":"2024-11-09 04:14","pubTimestamp":1731096874,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日04时14分，Uniqure N.V.股票出现异动，股价大幅上涨5.38%。截至发稿，该股报7.83美元/股，成交量51.0051万股，换手率1.05%，振幅8.48%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为1.19%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109041434971a572e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109041434971a572e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2481899679","title":"Uniqure N.V.盘中异动 早盘大幅拉升5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481899679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481899679?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:35","pubTimestamp":1730903729,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时35分，Uniqure N.V.股票出现异动，股价大幅拉升5.12%。截至发稿，该股报6.37美元/股，成交量2.3088万股，换手率0.05%，振幅104.62%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.17%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223530971a4c4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223530971a4c4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2481554478","title":"Uniqure N.V.盘中异动 股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481554478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481554478?lang=zh_cn&edition=full","pubTime":"2024-11-05 04:49","pubTimestamp":1730753387,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日04时49分，Uniqure N.V.股票出现异动，股价大幅跳水5.12%。截至发稿，该股报5.56美元/股，成交量45.1361万股，换手率0.93%，振幅5.46%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.42%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105044947ab9f52b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105044947ab9f52b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"gpt_icon":0},{"id":"2479367320","title":"Uniqure N.V.盘中异动 早盘股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479367320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479367320?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:29","pubTimestamp":1730384961,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时29分，Uniqure N.V.股票出现异动，股价急速跳水5.15%。截至发稿，该股报5.98美元/股，成交量6.5476万股，换手率0.13%，振幅3.97%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为2.83%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031222921971a392b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031222921971a392b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"gpt_icon":0},{"id":"2478819489","title":"Uniqure N.V.盘中异动 早盘急速拉升5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478819489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478819489?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:50","pubTimestamp":1730123430,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时50分，Uniqure N.V.股票出现异动，股价大幅拉升5.43%。截至发稿，该股报6.89美元/股，成交量3.6647万股，换手率0.08%，振幅4.74%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.63%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821503098e3ed37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821503098e3ed37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2478651916","title":"Uniqure N.V.盘中异动 临近午盘快速跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478651916","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478651916?lang=zh_cn&edition=full","pubTime":"2024-10-24 23:54","pubTimestamp":1729785295,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日23时54分，Uniqure N.V.股票出现波动，股价快速跳水5.05%。截至发稿，该股报6.11美元/股，成交量14.7434万股，换手率0.30%，振幅6.29%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.16%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024235455971a21c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024235455971a21c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"gpt_icon":0},{"id":"2477835493","title":"Uniqure N.V.盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477835493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477835493?lang=zh_cn&edition=full","pubTime":"2024-10-22 23:33","pubTimestamp":1729611202,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日23时33分，Uniqure N.V.股票出现异动，股价大幅跳水5.15%。截至发稿，该股报6.26美元/股，成交量37.3257万股，换手率0.77%，振幅8.64%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.34%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102223332298e3dce2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102223332298e3dce2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2477865578","title":"Uniqure N.V.盘中异动 早盘大幅跳水5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477865578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477865578?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:33","pubTimestamp":1729517601,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时33分，Uniqure N.V.股票出现波动，股价大幅下挫5.44%。截至发稿，该股报6.07美元/股，成交量3.3027万股，换手率0.07%，振幅2.80%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.04%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121332198e3d839&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121332198e3d839&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2473478351","title":"Uniqure N.V.盘中异动 早盘股价大涨5.33%报5.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473478351","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473478351?lang=zh_cn&edition=full","pubTime":"2024-10-08 21:33","pubTimestamp":1728394410,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日21时33分，Uniqure N.V.股票出现异动，股价快速拉升5.33%。截至发稿，该股报5.61美元/股，成交量3.1105万股，换手率0.06%，振幅5.44%。机构评级方面，在所有12家参与评级的机构中，67%的券商给予买入建议，33%的券商给予持有建议，无券商给予卖出建议。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.12%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100821333098e3b2a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100821333098e3b2a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"gpt_icon":0},{"id":"2473105294","title":"Uniqure N.V.盘中异动 股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473105294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473105294?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:34","pubTimestamp":1728308062,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时34分，Uniqure N.V.股票出现异动，股价大幅下跌5.24%。截至发稿，该股报5.35美元/股，成交量7.8454万股，换手率0.16%，振幅5.49%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.19%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007213422ab681a88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007213422ab681a88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2472595763","title":"Uniqure N.V.盘中异动 早盘股价大涨7.12%报4.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472595763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472595763?lang=zh_cn&edition=full","pubTime":"2024-10-04 21:31","pubTimestamp":1728048685,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日21时31分，Uniqure N.V.股票出现异动，股价急速上涨7.12%。截至发稿，该股报4.88美元/股，成交量5.2851万股，换手率0.11%，振幅1.97%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.12%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。其产品和服务专注于血友病、亨廷顿病和心血管疾病。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410042131259f292259&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410042131259f292259&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2469148980","title":"Uniqure N.V.盘中异动 早盘快速跳水5.04%报5.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469148980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469148980?lang=zh_cn&edition=full","pubTime":"2024-09-23 22:19","pubTimestamp":1727101186,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日22时19分，Uniqure N.V.股票出现波动，股价急速跳水5.04%。截至发稿，该股报5.09美元/股，成交量10.527万股，换手率0.22%，振幅4.85%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.80%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。消息层面，截至22时19分，Uniqure N.V.股票正面舆情新闻比例50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092322194698e38741&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092322194698e38741&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2468502578","title":"Uniqure N.V.盘中异动 大幅上涨5.03%报6.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468502578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468502578?lang=zh_cn&edition=full","pubTime":"2024-09-19 23:56","pubTimestamp":1726761361,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日23时56分，Uniqure N.V.股票出现波动，股价大幅上涨5.03%。截至发稿，该股报6.05美元/股，成交量18.3795万股，换手率0.38%，振幅5.90%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为1.70%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091923560198e38226&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091923560198e38226&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2459177479","title":"Uniqure N.V.盘中异动 早盘急速下挫5.26%报6.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459177479","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459177479?lang=zh_cn&edition=full","pubTime":"2024-08-14 21:59","pubTimestamp":1723643960,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日21时59分，Uniqure N.V.股票出现异动，股价大幅跳水5.26%。截至发稿，该股报6.67美元/股，成交量6.4545万股，换手率0.13%，振幅4.69%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.44%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814215920ab5dafa5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814215920ab5dafa5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2459135423","title":"Uniqure N.V.盘中异动 股价大跌5.26%报6.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459135423","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459135423?lang=zh_cn&edition=full","pubTime":"2024-08-14 02:50","pubTimestamp":1723575019,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日02时50分，Uniqure N.V.股票出现异动，股价急速下挫5.26%。截至发稿，该股报6.84美元/股，成交量44.9662万股，换手率0.92%，振幅7.62%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为1.50%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814025019942004ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814025019942004ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"gpt_icon":0},{"id":"2457482991","title":"Uniqure N.V.盘中异动 临近午盘快速下挫5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457482991","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457482991?lang=zh_cn&edition=full","pubTime":"2024-08-07 23:46","pubTimestamp":1723045562,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日23时46分，Uniqure N.V.股票出现波动，股价急速下挫5.29%。截至发稿，该股报7.16美元/股，成交量15.3806万股，换手率0.32%，振幅7.67%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为2.09%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807234603af966c09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807234603af966c09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2456230409","title":"高盛：维持uniQure(QURE.US)评级，由中性调整至中性评级, 目标价由6.00美元调整至10.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2456230409","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456230409?lang=zh_cn&edition=full","pubTime":"2024-08-03 01:00","pubTimestamp":1722618003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1668664300.SGD","LU2237438978.USD","BK4504","IE00BFXG1179.USD","BK4139","LU2237443549.SGD","LU1791807156.HKD","LU2237443382.USD","IE00B19Z3581.USD","QURE","BK4127","LU2237443622.USD","BK4585","BK4588","IE0034235188.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","IE0002270589.USD","BK4550","BK4533","LU0106831901.USD","BK4552","LU2237443978.SGD"],"gpt_icon":0},{"id":"2456825092","title":"Uniqure N.V.盘中异动 早盘股价大跌5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456825092","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456825092?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:51","pubTimestamp":1722606688,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时51分，Uniqure N.V.股票出现波动，股价急速下跌5.48%。截至发稿，该股报7.07美元/股，成交量12.3257万股，换手率0.25%，振幅4.41%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为1.23%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802215128aefcf9b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802215128aefcf9b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.uniqure.com","stockEarnings":[{"period":"1week","weight":-0.0915},{"period":"1month","weight":0.1968},{"period":"3month","weight":0.0212},{"period":"6month","weight":0.3473},{"period":"1year","weight":0.0143},{"period":"ytd","weight":-0.003}],"compareEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0704},{"period":"6month","weight":0.1207},{"period":"1year","weight":0.3195},{"period":"ytd","weight":0.2483}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"uniQure N.V.作为私人有限责任公司于2012年1月9日依照荷兰相关法律条文成立。uniQure公司在基因疗法领域是领导者，同时研发了第一个也是迄今为止唯一一个得到欧盟监管认可的基因疗法产品。通过引导治疗性蛋白基因或者通过的表达，或者通过单一管理修复缺失蛋白的表达，基因疗法向有基因或获得性疾病的患者提供长期而且潜在有效的利益。公司的第一个产品，即阿利泼金（Glybera），由于该药对脂蛋白脂酶缺乏（LPLD）患者治疗的极佳效果被欧洲委员会在2012年10月通过，上述疾病是具有潜在生命危险的孤儿代谢性疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":0.005086},{"month":2,"riseRate":0.6,"avgChangeRate":0.087111},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.041415},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.015715},{"month":5,"riseRate":0.727273,"avgChangeRate":0.048657},{"month":6,"riseRate":0.454545,"avgChangeRate":-0.006965},{"month":7,"riseRate":0.272727,"avgChangeRate":0.036195},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.009211},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.100177},{"month":10,"riseRate":0.454545,"avgChangeRate":0.051369},{"month":11,"riseRate":0.818182,"avgChangeRate":0.133559},{"month":12,"riseRate":0.2,"avgChangeRate":-0.032638}],"exchange":"NASDAQ","name":"uniQure N.V.","nameEN":"uniQure NV"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"uniQure N.V.(QURE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供uniQure N.V.(QURE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"uniQure N.V.,QURE,uniQure N.V.股票,uniQure N.V.股票老虎,uniQure N.V.股票老虎国际,uniQure N.V.行情,uniQure N.V.股票行情,uniQure N.V.股价,uniQure N.V.股市,uniQure N.V.股票价格,uniQure N.V.股票交易,uniQure N.V.股票购买,uniQure N.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"uniQure N.V.(QURE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供uniQure N.V.(QURE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}